OD-OS Inc. specializes in advanced retinal laser technology, particularly through its flagship product, the Navilas® Laser System. This innovative device is designed for the treatment of various vision-threatening retinal diseases, including Diabetic Macular Edema, Proliferative Diabetic Retinopathy, and Central Serous Chorioretinopathy. The Navilas® system integrates diagnostics with laser therapy, allowing retina specialists to perform pre-planned, computer-guided treatments that enhance accuracy, speed, and patient comfort. Its unique navigation technology, which includes integrated eye tracking, sets it apart from traditional laser systems, enabling more precise targeting and treatment of retinal conditions.

The Navilas® Laser System is recognized for its efficiency and effectiveness in retinal laser photocoagulation treatments. It supports a range of applications, from laser retinopexy to panretinal photocoagulation, and is designed to minimize collateral tissue damage while maximizing treatment outcomes. The system's 577nm yellow laser offers tissue-friendly microsecond pulsing and an anterior treatment mode, making it suitable for a variety of retinal indications. With its recent certification under the Medical Devices Regulation (EU MDR), OD-OS Inc. continues to uphold high standards in medical technology, paving the way for future advancements in retinal disease management.

United States

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases.

Join the Navilas mailing list: 
https://tinyurl.com/od-os-mailing-list

Follow us on Twitter: 
https://twitter.com/OD_OS_Navilas

Privacy Policy Social Media Pages:
https://www.od-os.com/legal-notice-container/privacy-policy/social-media

OD-OS Inc

Company Details